The latest news, stories and exciting findings from across the Oxford cancer research community
The great escape artist – how tracking co-evolution could improve immunotherapy
26 July 2024
Tumour cells escaping the immune system is a major cause of resistance to cancer immunotherapy. So how can we stop it? Audrey Gérard sat down with CRUK to discuss...
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
17 July 2024
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on ground-breaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.
Oxford hosts industry event on cancer precision prevention trials
17 July 2024
Professor Sarah Blagden led a panel discussion focused on the opportunities of cancer precision prevention.
Oxford success in the 2024 Lasker Essay Contest
16 July 2024
Subashan Vadibeler, a recent Oxford Rhodes scholar and MRes student, is one of five co-winners of our international 2024 Essay Contest sponsored by the Lasker Foundation.
OCION: In conversation with Felipe Galvez-Cancino
5 July 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor Felipe Galvez-Cancino, who has recently joined the Nuffield Department of Medicine, to discuss his research.
OxCODE researchers at the inaugural Cancer Prevention Research conference 2024
4 July 2024
Over 20 Oxford researchers engaged with over 350 attendees from all over the world at a truly interdisciplinary cancer prevention conference.
GambitBio: empowering early detection at home
2 July 2024
GambitBio is developing an at-home lateral flow test to screen for the most common cancers, empowering people to take control of their health and reduce the number of cancer-related deaths. CRUK recently interviewed CEO, Tiffany Ma, who co-founded the venture while completing her DPhil at the University of Oxford.
Professor Freddie Hamdy recognised in the King's Birthday Honours 2024
18 June 2024
Professor Freddie Hamdy, Nuffield Professor of Surgery and Head of the Nuffield Department of Surgical Sciences, has been appointed Commander of the Order of the British Empire (CBE) in the King's Birthday Honours 2024. The honour recognises his services to Surgical and Cancer Sciences.
OCION: In conversation with Dave Withers
17 June 2024
Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to apply Oxford's leading expertise in fundamental immunology to enable more patients, with a wide range of cancer types, to benefit safely from tailored immunotherapy use. We sat down with Professor David Withers, who recently moved to Oxford, to discuss his research.
Immunotherapy: finding hidden ways to treat cancer
13 June 2024
Giamp Valenzano, a DPhil in Cancer Science student, joins forces with Oxford Sparks to deliver a video explaining how his research on immunotherapy aims to help treat cancer
Oxford Cancer to host information evening for people affected by liver cancer
12 June 2024
Those affected by liver cancer are invited to an online information evening with our liver cancer experts. The event is due to take place on Thursday 3rd of October, between 5 – 7 pm.
Glowing dye helps surgeons eradicate prostate cancer
10 June 2024
A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study funded by Cancer Research UK.
Oxford Cancer Immuno-Oncology Network 2024 Symposium
10 June 2024
Fantastic day of immuno-oncology talks and networking at this years' annual OCION Symposium!
OCION 2024 Funding Scheme is live!
7 June 2024
The 2024 Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is now open!
Launch of the Oxford Translational Data Platform
3 June 2024
The Oxford Cancer Centre and the Oxford ECMC are launching a new data initiative to maximize the discovery potential of samples and information collected during clinical trials.
Prof Anindita Roy awarded CRUK funding to study infant acute lymphoblastic leukaemia
30 May 2024
Congratulations to Professor Anindita Roy who successfully applied for a CRUK Data4CYP award!
Oxford Cancer: 5 minutes with Professor Dame Molly Stevens
23 May 2024
Professor Dame Molly Stevens is John Black Professor of Bionanoscience in the Department of Physiology, Anatomy and Genetics and the Institute of Biomedical Engineering. She recently moved her lab from Imperial College London to the University of Oxford and the Kavli Institute for nanoscience discovery, and she is joining the Oxford Cancer community.
Oxford Cancer researchers elected as Fellows of the Academy of Medical Sciences
22 May 2024
The Academy of Medical Sciences has elected four Oxford Cancer biomedical and health scientists to its fellowship in 2024.
Oxford Cancer Professor Yang Shi honoured by the Royal Society
16 May 2024
Ludwig Oxford Professor Yang Shi has been elected as a Fellow of the Royal Society for his contributions to epigenetics research.
Blood proteins may be able to predict risk of cancer more than seven years before it is diagnosed
15 May 2024
Proteins linked to cancer can start appearing in people’s blood more than seven years before they’re diagnosed. In the future, it’s possible doctors could use these early warning signs to find and treat cancer much earlier than they’re able to today.